ESR1 and breast carcinoma: We wanted to examine if ERα-AREG signalling is also CITED1-mediated in breast cancer cells and the relatively low levels of CITED1 in MCF7s compared to other luminal-types made them ideal for development of a CITED1-overexpression model (Figs. 1b, 3a, b).